OraSure Technologies Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Go Beyond the Preview – Access the Full Value Chain Analysis
This OraSure Technologies Value Chain Analysis gives you a clear, company-specific view of how OraSure Technologies creates value across support and primary activities. The page already shows a real preview of the analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
OraSure Technologies' firm infrastructure is built on finance, legal, quality, and compliance teams that keep FDA and diagnostic rules aligned with product work. In fiscal 2025, that matters because the company has to coordinate launches, audits, and controls across a regulated diagnostics base without slipping on quality. This backbone helps OraSure Technologies manage risk, protect approvals, and keep operations moving.
Human Resource Management
In FY2025, OraSure Technologies' Human Resource Management is a control point in the value chain because it must hire and keep scientists, manufacturing technicians, quality specialists, regulatory staff, and commercial teams.
Training matters because regulated diagnostics depend on disciplined work from development through complaint handling, lot release, and post-market follow-up.
Retention also protects speed and quality, since one weak hire can raise rework, delays, and compliance risk.
Technology Development
In fiscal 2025, OraSure Technologies kept R&D at the core of technology development because its edge comes from test performance, not price. The work focuses on assay design, sample stability, usability, and shelf life across point-of-care tests and molecular collection products, which directly affects adoption in regulated diagnostics markets. That matters because even small gains in sensitivity or storage life can widen clinical use and support higher-margin products.
Procurement
Procurement at OraSure Technologies secures reagents, plastics, packaging, and other controlled inputs for diagnostics and specimen collection devices. In a business that reported about $200 million in annual revenue, tight supplier control matters because even small shortages can disrupt output and squeeze gross margin.
Strong sourcing and vendor qualification help protect product quality, reduce lead-time risk, and keep costs steadier when demand shifts. That matters most for regulated inputs, where a missed spec can delay shipments and hurt service levels.
OraSure's FY2025: Compliance, Quality, and Steadier Delivery
In fiscal 2025, OraSure Technologies' support activities were built to protect regulated execution: finance, legal, quality, compliance, HR, R&D, and procurement all had to keep launches, audits, hiring, and supplier control tight. With about $200 million in annual revenue, even small control gaps can hit output and gross margin. The result is a value chain geared to compliance, product quality, and steadier delivery.
| Area | FY2025 signal |
|---|---|
| Revenue | About $200 million |
| Priority | Compliance and quality control |
| Risk | Supplier or hiring gaps |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
OraSure Technologies' inbound logistics centers on tightly controlled receipt of regulated raw materials, reagents, and device parts, with inspection at intake to protect product integrity. That matters because any contamination or lot error can stop a compliant test run fast. In 2025, the focus stayed on traceable sourcing, inventory accuracy, and steady line supply so manufacturing could keep moving without quality slips.
Operations
Operations turn raw materials into OraSure Technologies diagnostic kits and specimen collection devices through assembly, assay manufacturing, validation, and quality testing, so yield and compliance drive gross margin. In fiscal 2025, this step remains the main cost lever: fewer rejects, tighter batch control, and higher throughput lower unit cost, while any rework or regulatory miss can hit margin fast.
Outbound Logistics
OraSure Technologies uses outbound logistics to ship diagnostics and sample-collection products to laboratories, public health buyers, retailers, distributors, and research customers. In 2025, this step matters because many buyers need fast, accurate delivery to keep testing programs and clinical workflows on time. Strong fulfillment cuts stockouts, protects service levels, and supports repeat orders.
Marketing and Sales
In 2025, OraSure Technologies markets infectious disease tests, substance abuse screening products, and collection kits to clinical, public health, retail, and research buyers. The pitch is simple: easy use, regulatory clearance, and clear value for self-testing and sample quality, which helps support repeat orders and broader adoption.
Service
OraSure Technologies uses Service to provide technical support, training, complaint handling, and customer documentation after sale. In regulated diagnostics, that work matters because correct use, result reading, and sample handling can change repeat orders and customer trust. It also helps protect quality in products like OraQuick, where training and clear instructions support consistent field use.
OraSure Technologies' 2025 Value Chain: Where Margin and Loyalty Are Won
OraSure Technologies' primary activities in fiscal 2025 stayed centered on five steps: inbound logistics, operations, outbound logistics, marketing and sales, and service. Each one ties directly to regulated diagnostics, so traceability, yield, delivery speed, and customer support all affect margin and repeat orders.
| Primary activity | 2025 focus |
|---|---|
| Operations | Major cost and margin driver |
| Service | Support, training, complaints |
Preview the Actual Deliverable
OraSure Technologies Reference Sources
This is the actual OraSure Technologies Value Chain Analysis document you'll receive upon purchase – no surprises, just professional quality. The preview below is taken directly from the full report, so what you see here is the same file delivered after checkout. Purchase unlocks the complete, detailed version.
Frequently Asked Questions
OraSure Technologies' value chain emphasizes regulated diagnostics, specimen collection, and commercialization across 4 support activities and 5 primary activities. The business is built around 3 demand pools: infectious disease testing, substance abuse screening, and molecular sample collection. That mix rewards compliance, reliable manufacturing, and strong channel execution.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.